-
Mashup Score: 7SOC cilta-cel evaluated for relapsed/refractory multiple myeloma - 18 day(s) ago
Sidana S, Patel KK, Peres LC, et al. Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma. Blood. 2024; (doi:…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Translational Science Training Course - 18 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 1Become a Member Today - 21 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
For a limited time, join ASTCT now and become a member through 2025 with our extended membership option! Learn more about the benefits of an ASTCT membership and join now: https://t.co/amWRieR9H6 https://t.co/avnoyV1gUN
-
-
Mashup Score: 4Translational Science Training Course - 26 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 1Become a Member Today - 30 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
For a limited time, join ASTCT now and become a member through 2025 with our extended membership option! Learn more about the benefits of an ASTCT membership and join now: https://t.co/amWRieR9H6 https://t.co/avnoyV1gUN
-
-
Mashup Score: 0Leadership Course - 1 month(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
🌟 Calling all emerging leaders in the transplant and cellular therapy field! 🌟 Sharpen your leadership skills, network with industry experts and take your career to the next level with the 2025 Leadership Course. Applications are now open: https://t.co/hczPev3teU https://t.co/pTtDLUy6qP
-
-
Mashup Score: 0Leadership Course - 1 month(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
🌟 Calling all emerging leaders in the transplant and cellular therapy field! 🌟 Sharpen your leadership skills, network with industry experts and take your career to the next level with the 2025 Leadership Course. Applications are now open: https://t.co/hczPev3teU https://t.co/pTtDLUy6qP
-
-
Mashup Score: 2Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach - 1 month(s) ago
Welcome to the first installment of an exclusive 8-part ASTCT Talks series, supported by an educational grant from Sanofi US. In this series, ASTCT President Dr. Corey Cutler speaks with authors…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
In this special ep. of the podcast, ASTCT President Dr. Corey Cutler speaks with Dr. Katie Luo, a leading ophthalmologist to discuss ocular cGVHD. Thanks to Sanofi US for their support via an educational grant. Listen now: https://t.co/Ig61yJhX2y https://t.co/bsVQnfRoCU
-
-
Mashup Score: 8Toxicities Conference - 1 month(s) ago
November 15 – 16, 2024, Philadelphia, Pennsylvania. The conference brings together experts and thought leaders from around the world to discuss the mechanism of toxicities and symptom burden after hematopoietic cell transplantation (HCT) and cellular and gene therapies; current advances in the field; and best practices to both prevent and treat these toxicities and symptoms.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
NEW 🤩 Abstract & meeting opportunity: This fall, ASTCT is hosting the 4th International Conference on Toxicities of Transplantation & Cellular Therapies and we are currently accepting abstracts! Learn more: https://t.co/06gEoPDeDs https://t.co/Z9L0QQKJj7
-
-
Mashup Score: 8Toxicities Conference - 1 month(s) ago
November 15 – 16, 2024, Philadelphia, Pennsylvania. The conference brings together experts and thought leaders from around the world to discuss the mechanism of toxicities and symptom burden after hematopoietic cell transplantation (HCT) and cellular and gene therapies; current advances in the field; and best practices to both prevent and treat these toxicities and symptoms.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
NEW 🤩 Abstract & meeting opportunity: This fall, ASTCT is hosting the 4th International Conference on Toxicities of Transplantation & Cellular Therapies and we are currently accepting abstracts! Learn more: https://t.co/06gEoPDeDs https://t.co/Z9L0QQKJj7
-
Evidence suggests cilta-cel generates a durable response in patients with r/r multiple myeloma, even those who would not have qualified for participation in the clinical study underpinning its approval. Read more on Nucleus: https://t.co/4ZRfAoDdlW https://t.co/AuaOoNaHRB